Long-term efficacy of aripiprazole in pediatric patients with bipolar I disorder

被引：0
|
作者：
Forbes, R. [1 ]
Werner, C. [3 ]
Nyilas, M. [2 ]
Jin, N. [4 ]
Johnson, B. [5 ]
Owen, R. [6 ]
Iwamoto, T. [7 ]
Carson, W. [5 ]
机构：
[1] Otsuka Pharmaceut Co Ltd, Global Med Affairs, Princeton, NJ USA
[2] Otsuka Pharmaceut Co Ltd, Global Clin, Princeton, NJ USA
[3] Otsuka Pharmaceut Co Ltd, Frankfurt, Germany
[4] Otsuka Pharmaceut Co Ltd, Biostat, Princeton, NJ USA
[5] Otsuka Pharmaceut Co Ltd, Clin Dev, Princeton, NJ USA
[6] Bristol Myers Squibb Co, Clin Dev, Wallingford, CT 06492 USA
[7] Otsuka Pharmaceut Co Ltd, Corp Management, Princeton, NJ USA
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2008年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：184 / 184
页数：1
相关论文
共 50 条
  • [1] Long-term tolerability and safety of aripiprazole in pediatric patients with schizophrenia or bipolar I disorder
    Nyilas, M.
    Correll, C.
    Werner, C.
    Forbes, R.
    Johnson, B.
    Aurang, C.
    Jin, N.
    Owen, R.
    Iwamoto, T.
    Carson, W.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 133 - 134
  • [2] LONG-TERM TOLERABILITY AND SAFETY OF ARIPIPRAZOLE IN THE TREATMENT OF PEDIATRIC PATIENTS WITH SCHIZOPHRENIA OR BIPOLAR I DISORDER
    Forbes, Robert A.
    Nyilas, M.
    Johnson, B.
    Aurang, C.
    Owen, R.
    Iwamoto, T.
    Carson, W. H.
    Correll, C.
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 362 - 363
  • [3] Efficacy and tolerability of long-term aripiprazole treatment in a patient with bipolar I disorder
    De Berardis, D.
    Serroni, N.
    Campanella, D.
    Moschetta, F. S.
    Ferro, F. M.
    JOURNAL OF PSYCHOPATHOLOGY, 2009, 15 (01): : 99 - 101
  • [4] Sustained remission in bipolar I disorder: an analysis of an aripiprazole long-term bipolar study
    Masand, P.
    Eudicone, J.
    Pikalov, A.
    McQuade, R.
    Marcus, R.
    Carlson, B.
    BIPOLAR DISORDERS, 2007, 9 : 75 - 75
  • [5] Long-Term Efficacy of Aripiprazole in Children (Ages 10-17 Years) With Bipolar I Disorder
    Nyilas, Margaretta
    Forbes, Andy
    Jin, Na
    Johnson, Brian
    McQuade, Robert
    Owen, Randall
    Carson, William H.
    Findling, Robert L.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2008, 18 (06) : 635 - 635
  • [6] Aripiprazole in combination with lamotrigine: long-term treatment of patients with bipolar I disorder (manic or mixed)
    Ketter, T.
    Carlson, B. X.
    Sun, W.
    Timko, K.
    Vester-Blokland, E.
    McQuade, R. D.
    Sanchez, R.
    Owen, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S413 - S414
  • [7] Long-term use of open label aripiprazole as augmentation therapy in bipolar I and bipolar II disorder
    Schweitzer, Isaac
    Ng, Chee
    Crowley, K. C.
    Dyson, Jessica
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2007, 41 : A78 - A78
  • [8] Olanzapine: Acute and long-term efficacy in bipolar I patients
    Tohen, M
    Jacobs, T
    Gannon, KS
    Sanger, TM
    Greaney, M
    Toma, V
    Tollefson, GD
    SCHIZOPHRENIA RESEARCH, 2000, 41 (01) : 192 - 193
  • [9] Long-term safety and efficacy of olanzapine in the treatment of japanese patients with bipolar I disorder, depressed
    Katagiri, H.
    Tohen, M.
    McDonnell, D. Patrick
    Fujikoshi, S.
    Case, M.
    Kanba, S.
    Takahashi, M.
    Gomez, J. -C.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 82 - 83
  • [10] Effect of aripiprazole in combination with lamotrigine in the long-term maintenance of patients with bipolar I disorder (CN138-392)
    Rahman, Z.
    Fyans, P.
    Eudicone, J. M.
    Forbes, R. A.
    Baker, R. A.
    Carlson, B. X.
    BIPOLAR DISORDERS, 2011, 13 : 79 - 80
12345